VIR has a couple of interesting products testing in the pipeline. The one that caused the spike in Jan is for hepatitis B treatment. And the selloff today is caused by the pause in the enrollment of late-stage trial testing of their Covid19 antibody. So it seems it is safe to assume that it will return above previous resistance of 53. With 80's as a first target,...
I am not a fan of TSLA, I (have always :)) considered it extremely overvalued, and it still may be the case. However it looks like a buying opportunity. First, 500 was a resistance. Then second time resistance, and turned into support. Will it stand this level this time? RSI is 26.8, and it was lower only during the first covid drop last year. It was lower...
GNCA is heading higher for 3 months now on increasing volume, and seems confirming another support level. Will take some, take-profit @ 5.50.
Looks like it’s going to test 1.56 support these days. If it stands it, it may be a good buy signal.
this one has two gaps to be filled, so may be risky. going long with a tight stop-loss. target - previous highs. if it drifts lower, will wait till the gaps are filled before buying again.
What used to be a resistance now a support. Plus an inverse head & shoulders. Plus positive news: “Supernus said that a Phase 3 trial 'met the primary endpoint ... compared to placebo in improving the symptoms of ADHD.'" Going long anticipating 30’s where MA200 is and then maybe higher. With tight stop-loss just behind the support.
COGT has been trading in the range during 7 months. Being close to the support it gives an opportunity to buy it with a tight stop-loss just below the support level. Potential profit: 1) 40-50% if bought close to the support at 8.40 and sold as close as possible to resistance at 13.28. But I would not bet on buying cheaper than 9.00 as it is where it meets MA200,...
MRNA could possibly reach as high as 250’s before or after the earnings report on 10 Mar. Not only it may beat the earnings estimate, there are also quite positive news which may lead to explosive growth. First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research NEW YORK and LA JOLLA, CA—A phase 1 clinical trial...
IMUX has been trading in the channel for over 6 months. Now it seems it is trying to break it. If it stands the support at 20.20 (used to be resistance), it may look like a good BUY signal. Alternatively, can try to wait if it drops back to the support at 15.00. I think I will give it a try now.
If you want to short Bitcoin, this is one of the options - inverse Bitcoin ETP on SIX Swiss Exchange. I will not discuss here why would you and whether you should, this is just to outline the possibility. And as a final note - I am buying some.
The stock has been above $5 most of the time. It is only that Lenbasaum, their leading drug, has failed in one of the clinical studies, that is why the stock plummeted in Sep 2020. Nonetheless, they have couple others ongoing studies and they may have a chance to recover to pre-covid levels. Before the September news their ratings were Buy and Outperform at $12,...
If it finds support here at 1.7 - buying in 1.7-1.8 range, target 2.1. Alternatively, buying at 1.3-1.4, target 1.7.
I am buying it at 31-32 if it finds the support within next 1-2 weeks. If not - alternatively will buy at 22-26 level. Take-profit - 44.
If it breaks the trend line at 5, we may see resistance test at 6.1 again. If 5 is not broken, then back to 4.4 support testing. Looks like 4.4 should not be broken so sooner or later we will see 6.
OGC has been trading in the 1.3-5.00 range for 10 years now. I guess I am closing my position at 3.00-3.40 and will just watch the stock from there on.
Expect it to return to pre-covid levels. Maybe with 10-20% discount. Overall their business seems safe. Take profit - 25. Or maybe even to keep it long-term, depending on how they will pay dividends.
I see couple of gaps to be filled here. So the question is - where do we go first? Will the lower gap be filled during the shopping frenzy? Do not think so. Moreover - do we see a golden cross forming here??? Yep! So first we go to 95-100 in Jan, and then (maybe…) back to 60’s in Feb-Mar.
"When Tesla CEO Elon Musk urged his Twitter followers on Thursday to “use Signal,” he meant the encrypted messaging app. Some people appear to have taken it the wrong way. Shares of an obscure and unrelated company called Signal Advance, which trades over the counter, surged 527% on Thursday and another 91% on Friday, climbing from 60 cents to $7.19." Naturally,...